Metabolic phenotyping of human plasma by 1H-NMR at high and medium magnetic field strengths: a case study for lung cancer

Magnetic Resonance in Chemistry

Volumn 55, Issue 8, 2017, Pages 706-713

  Louis, Evelyne ^a   Cantrelle, Francois Xavier ^b   Mesotten, Liesbet ^a,c   Reekmans, Gunter ^d   Bervoets, Liene ^a   Vanhove, Karolien ^a,e   Thomeer, Michiel ^a,c   Lippens, Guy ^b,f   Adriaensens, Peter ^d  

^a HASSELT UNIVERSITY   (Belgium)

^b UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

^c DEPARTMENT OF CARDIOLOGY   (Belgium)

^d HASSELT UNIVERSITY   (Belgium)

^e INRA ^*  (Belgium)

^f INSA   (France)

Author keywords

1H, magnetic field strength; lung cancer; metabolic phenotype; nuclear magnetic resonance spectroscopy; plasma

Indexed keywords

BIOMOLECULES; COPYRIGHTS; MAGNETIC FIELDS; MAGNETOPLASMA; MULTIVARIANT ANALYSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SIGNAL TO NOISE RATIO;

1H, MAGNETIC FIELD STRENGTH; 900 MHZ; CASE-STUDIES; HUMAN PLASMAS; LUNG CANCER; MAGNETIC FIELD STRENGTHS; METABOLIC PHENOTYPE; NMR SPECTRUM; PHENOTYPING; PLASMA METABOLITES;

METABOLITES;

ADULT; AGED; BLOOD; CASE CONTROL STUDY; FACTUAL DATABASE; FEMALE; HUMAN; LUNG TUMOR; MAGNETIC FIELD; MALE; METABOLOMICS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHENOTYPE; PROCEDURES; SIGNAL NOISE RATIO; STATISTICAL MODEL; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DATABASES, FACTUAL; FEMALE; HUMANS; LUNG NEOPLASMS; MAGNETIC FIELDS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOMICS; MIDDLE AGED; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; PHENOTYPE; SIGNAL-TO-NOISE RATIO; YOUNG ADULT;

EID: 85013961688     PISSN: 07491581     EISSN: 1097458X     Source Type: Journal    
DOI: 10.1002/mrc.4577     Document Type: Article

References (28)

1. K. Hollywood, D. R. Brison, R. Goodacre. Proteomics 2006, 6(17), 4716–4723.
2. J. K. Nicholson, J. C. Lindon, E. Holmes. Xenobiotica 1999, 29(11), 1181–1189.
3. A. C. Dona, B. Jimenez, H. Schafer, E. Humpfer, M. Spraul, M. R. Lewis, J. T. Pearce, E. Holmes, J. C. Lindon, J. K. Nicholson. Anal. Chem. 2014, 86(19), 9887–9894.
4. J. C. Lindon, J. K. Nicholson. Annu. Rev. Anal. Chem. 2008, 1(1), 45–69.
5. M. Eliasson, S. Rannar, J. Trygg. Curr. Pharm. Biotechnol. 2011, 12(7), 996–1004.
6. R. Madsen, T. Lundstedt, J. Trygg. Anal. Chim. Acta 2010, 659(1–2), 23–33.
7. J. Trygg, E. Holmes, T. Lundstedt. J. Proteome Res. 2007, 6(2), 469–479.
8. M. E. Dumas, E. C. Maibaum, C. Teague, H. Ueshima, B. Zhou, J. C. Lindon, J. K. Nicholson, J. Stamler, P. Elliott, Q. Chan, E. Holmes. Anal. Chem. 2006, 78(7), 2199–2208.
9. E. Garcia, C. Andrews, J. Hua, H. L. Kim, D. K. Sukumaran, T. Szyperski, K. Odunsi. J. Proteome Res. 2011, 10(4), 1765–1771.
10. E. Jobard, C. Pontoizeau, B. J. Blaise, T. Bachelot, B. Elena-Herrmann, O. Tredan. Cancer Lett. 2014, 343(1), 33–41.
11. E. E. Kline, E. G. Treat, T. A. Averna, M. S. Davis, A. Y. Smith, L. O. Sillerud. J. Urol. 2006, 176(5), 2274–2279.
12. D. Kumar, A. Gupta, A. Mandhani, S. N. Sankhwar. J. Proteome Res. 2015, 14(3), 1455–1464.
13. C. M. Rocha, J. Carrola, A. S. Barros, A. M. Gil, B. J. Goodfellow, I. M. Carreira, J. Bernardo, A. Gomes, V. Sousa, L. Carvalho, I. F. Duarte. J. Proteome Res. 2011, 10(9), 4314–4324.
14. L. Zhang, H. Jin, X. Guo, Z. Yang, L. Zhao, S. Tang, P. Mo, K. Wu, Y. Nie, Y. Pan, D. Fan. Clin. Biochem. 2012, 45(13–14), 1064–1069.
15. T. A. Fedele, A. C. Galdos-Riveros, H. Jose de Farias e Melo, A. Magalhaes, D. A. Maria. Biomed. Pharmacother. 2013, 67(2), 146–156.
16. H. C. Bertram, A. Malmendal, B. O. Petersen, J. C. Madsen, H. Pedersen, N. C. Nielsen, C. Hoppe, C. Molgaard, K. F. Michaelsen, J. O. Duus. Anal. Chem. 2007, 79(18), 7110–7115.
17. E. Louis, L. Bervoets, G. Reekmans, E. De Jonge, L. Mesotten, M. Thomeer, P. Adriaensens. Metabolomics 2015, 11(1), 225–236.
18. E. Louis, P. Adriaensens, W. Guedens, T. Bigirumurame, K. Baeten, K. Vanhove, K. Vandeurzen, K. Darquennes, J. Vansteenkiste, C. Dooms, Z. Shkedy, L. Mesotten, M. Thomeer. J. Thorac. Oncol. 2016, 11(4), 516–523.
19. T. M. O'Connell. Bioanalysis 2012, 4(4), 431–451.
20. C. Zheng, S. Zhang, S. Ragg, D. Raftery, O. Vitek. Bioinformatics 2011, 27(12), 1637–1644.
21. P. Goldstraw, J. Crowley, K. Chansky, D. J. Giroux, P. A. Groome, R. Rami-Porta, M. P. Postmus, V. Rusch, L. Sobin. J. Thorac. Oncol. 2007, 2(8), 706–714.
22. J. Trygg, S. Wold. J. Chemometr. 2002, 16(3), 119–128.
23. J. Xia, D. I. Broadhurst, M. Wilson, D. S. Wishart. Metabolomics 2013, 9(2), 280–299.
24. S. Wiklund, E. Johansson, L. Sjostrom, E. J. Mellerowicz, U. Edlund, J. P. Shockcor, J. Gottfries, T. Moritz, J. Trygg. Anal. Chem. 2008, 80(1), 115–122.
25. M. Kriat, J. Vion-Dury, S. Confort-Gouny, R. Favre, P. Viout, M. Sciaky, H. Sari, P. J. Cozzone. J. Lipid Res. 1993, 34(6), 1009–1019.
26. M. Oostendorp, U. F. Engelke, M. A. Willemsen, R. A. Wevers. Clin. Chem. 2006, 52(7), 1395–1405.
27. A. Papathanasiou, C. Kostara, M. T. Cung, K. Seferiadis, M. Elisaf, E. Bairaktari, I. A. Goudevenos. Hellenic J. Cardiol. 2008, 49(2), 72–78.
28. E. M. Lenz, J. Bright, I. D. Wilson, S. R. Morgan, A. F. Nash. J. Pharm. Biomed. Anal. 2003, 33(5), 1103–1115.